Inferior Calcaneal Nerve Radiofrequency Ablation for Chronic Heel Pain
ICN-RF
Ultrasound-Guided Radiofrequency Ablation of the Inferior Calcaneal Nerve for Chronic Refractory Heel Pain: A Prospective Pilot Study
1 other identifier
interventional
31
1 country
1
Brief Summary
This prospective single-arm pilot interventional study aims to evaluate the effectiveness of ultrasound-guided radiofrequency ablation of the inferior calcaneal nerve in patients with chronic heel pain refractory to conservative treatments. Patients with plantar fasciitis or calcaneal spur who have not responded to multiple treatment modalities, including exercise, nonsteroidal anti-inflammatory drugs, orthotics, extracorporeal shockwave therapy, and corticosteroid injections, will be included. The procedure will be performed under ultrasound guidance. Pain intensity, functional status, and patient satisfaction will be assessed at baseline and at 1 and 3 months after the intervention. The primary outcome is treatment success, defined as a ≥50% reduction in pain intensity at 1 month compared to baseline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedFirst Submitted
Initial submission to the registry
April 12, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedApril 17, 2026
April 1, 2026
1 year
April 12, 2026
April 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity (Numeric Rating Scale, NRS)
Pain intensity is assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain severity. Treatment success is defined as a ≥50% reduction in NRS score compared to baseline.
Baseline to 1 months
Secondary Outcomes (4)
Change in Pain Intensity (Numeric Rating Scale, NRS)
Baseline to 3 months
Treatment Success Rate (≥50% Reduction in NRS)
1 month and 3 months
Marked Improvement Rate (≥80% Reduction in NRS)
1 month and 3 months
Foot Function Index (FFI)
Baseline, 1 month, and 3 months
Study Arms (1)
Radiofrequency Ablation of the Inferior Calcaneal Nerve
EXPERIMENTALParticipants with chronic heel pain associated with plantar fasciitis receive ultrasound-guided radiofrequency ablation of the inferior calcaneal (Baxter) nerve.
Interventions
Ultrasound-guided radiofrequency ablation of the inferior calcaneal (Baxter) nerve is performed under sterile conditions. The target nerve is identified using a high-frequency linear ultrasound transducer. A radiofrequency needle is advanced to the vicinity of the nerve, and thermal lesioning is applied according to standard protocols to achieve pain relief.
Eligibility Criteria
You may qualify if:
- Age between 18 and 75 years
- Chronic heel pain lasting longer than 6 months
- Clinical (tenderness and/or pain at the medial calcaneal tubercle) and radiological (X-ray or ultrasound) diagnosis of plantar fasciitis or calcaneal spur
- Refractory to at least four conservative treatment modalities, including exercise therapy, orthotic support (silicone heel pad), nonsteroidal anti-inflammatory drugs, extracorporeal shockwave therapy, and/or corticosteroid injection
You may not qualify if:
- History of trauma to the foot or ankle
- History of foot or ankle surgery
- Presence of systemic inflammatory disease
- Presence of peripheral neuropathy or S1 radiculopathy
- Pregnancy
- Hemodynamic instability
- Presence of skin or soft tissue infection at the injection site
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Şahide Eda Artuçlead
Study Sites (1)
University of Health Sciences Türkiye, Ankara Gaziler Physical Medicine and Rehabilitation Training and Research Hospital
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Şahide Eda Artuç, MD
University of Health Sciences Türkiye, Ankara Gaziler Physical Medicine and Rehabilitation Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Physiatrist (Specialist in Physical Medicine and Rehabilitation)
Study Record Dates
First Submitted
April 12, 2026
First Posted
April 17, 2026
Study Start
March 31, 2025
Primary Completion
March 31, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share